SOMASCAN PROTEOMIC ASSAY
Advanced and Innovative Technology in Early Detection of Asbestos-Related Malignant Pleural Mesothelioma
DOI:
https://doi.org/10.53366/jimki.v9i2.477Keywords:
asbestos, malignant pleural mesothelioma, SOMAscan proteomic assayAbstract
ABSTRACT
Introduction: Asbestos, as an air pollutant, is a global health problem. Asbestos exposure has been a cause of lung disease since 1930 and the number of cases continues to increase along with the use of asbestos in industry. Asbestos-Related Malignant Pleural Mesothelioma (MPM) is a primary pleural neoplasm caused by asbestos exposure, which has a high malignancy rate, and has diagnostic challenges so that the prognosis of MPM tends to be worse than other neoplasms. Therefore, an early detection is needed for high-risk groups exposed to asbestos in order to reduce the risk of morbidity and mortality from MPM. This literature study aims to review a SOMAscan Proteomic Assay tool as a cutting-edge and innovative technology for early detection of MPM.
Methods: This literature was written using the literature study method using trusted search engines, such as Science Direct and PubMed.
Discussion: SOMAscan Proteomic Assay (SOMALogic, Inc.; Boulder, CO, USA) is an aptamer-based multiplex proteomic technology capable of detecting protein biomarkers. This tool uses 13 types of serum-based proteins with an accuracy of 92% to detect mesothelioma cancer in high-risk populations exposed to asbestos. The sensitivity of this tool to detect MPM will be correlating even more the higher pathological stage is.
Conclusion: With high accuracy in the early stages, the SOMAscan Proteomic Assay is a promising tool for early diagnosis of MPM so that it has a greater chance of successful multimodality therapy with better prognosis.
Downloads
Published
Issue
Section
License
Authors retain copyright and grant JIMKI the right of first publication. Articles are published under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), permitting sharing and adaptation for non-commercial purposes with appropriate attribution to the authors and the original publication.




